Abstract
Optimizing medical management is recommended in the treatment of chronic obstructive pulmonary disease (COPD) exacerbations. When standard medical therapy alone is inadequate to relieve acute symptoms, ventilator support may be needed. Noninvasive positive pressure ventilation (NIPPV) is a device that provides ventilation support for select group of patients during COPD exacerbation based on criteria developed and supported from both randomized and nonrandomized control trials. NIPPV has been demonstrated to be of benefit in COPD exacerbation management, especially when used early before patient decompensation. This treatment option may be the difference between invasive endotracheal intubation and intensive care unit admission. For best outcomes, adhering to recommended and evidence-based care standards is very important when NIPPV is used.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
